With a revenue increase of 0.06% in the fourth quarter 2025, year on year to cumulative value of $29,184 million, Takeda Pharmaceutical Limited's revenue per employee grew on a trailing twelve months basis to $ 620,934. The productivity of Takeda Pharmaceutical Limited's employees was 0.0%, above the company average.
Within the Healthcare sector Employees of 147 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 1367, from total ranking in previous quarter at 1466. Takeda Pharmaceutical Limited has 47,000 employees.

What is Sales per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Revenue per Employee▼

None ▼

Revenue per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TAK Revenue per Employee	(Mar 31 2025) IV. Quarter	0 III. Quarter	0 II. Quarter	0 I. Quarter	(Mar 31 2024) IV. Quarter
Y / Y Revenue Change	0.06 %	-	-	-	4.53 %
Sales per Employee (TTM) $	620,934	620,568	620,568	620,568	620,568
TAK's Total Ranking	# 1367	# 1466	#	#	#
Seq. Revenue Change	-	-	-	-	-

TAK Company Profile >> Back to TAK Efficiency Comparisons >> Compare TAK Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 93
Healthcare Sector	# 148
Overall Market	# 1367

Revenue per Employee Statistics
High	Average	Low
$ 583,678	$ 575,019	$ 558,047
(Mar 31 2025)		(Mar 31 2023)

Financial Statements
Takeda Pharmaceutical Limited's Revenue MRQ	$ 29,184 Millions	Visit TAK's Income Statement
Takeda Pharmaceutical Limited's Revenues TTM	$ 29,184 Millions	Visit TAK's aggregate revenue growth
What are TAK's Sales?		Visit TAK's Sales by Segment

Other Ratios
Takeda Pharmaceutical Limited's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
TAK's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for TAK's Competitors
Revenue per Employee for TAK's Suppliers
Revenue per Employee for TAK's Customers

You may also want to know
TAK's Sales Growth Rates	TAK's Pe Price to earnings ratio	TAK's Receivables Turnover Ratio	TAK's Stock Quote
TAK's Net Income Growth Rates	TAK's Ps Price to Sales ratio	TAK's Sales per Employee	TAK's Asset Turnover Ratio
TAK's Net Margin	TAK's Pb Price to Book ratio	TAK's Financial Strength Ratios	TAK's Dividend Payout Ratio

Date modified: 2026-07-07T13:58:33+00:00

Companies with similar Revenue per Employee for 12 months ending Mar 31 2025, within Healthcare Sector	Revenue per Employee	Revenue 12 months ending Mar 31 2025	Number of Employees Mar 31 2025
Anaptysbio Inc	1,075,692.31	$ 111.872 Million	104
Emergent Biosolutions Inc	1,072,666.67	$ 965.400 Million	900
Dynavax Technologies Corporation	1,071,345.45	$ 294.620 Million	275
Integrated Biopharma Inc	1,067,540.00	$ 53.377 Million	50
Monte Rosa Therapeutics Inc	1,063,246.67	$ 159.487 Million	150
Amicus Therapeutics inc	1,060,475.54	$ 541.903 Million	511
Apellis Pharmaceuticals Inc	1,049,849.80	$ 775.839 Million	739
Supernus Pharmaceuticals inc	1,024,535.28	$ 667.997 Million	652
Mirum Pharmaceuticals Inc	1,019,491.94	$ 379.251 Million	372
Abbvie Inc	1,006,438.60	$ 57,367.000 Million	57,000
Lifevantage Corp	993,390.13	$ 221.526 Million	223
Eli Lilly And Company	980,064.00	$ 49,003.200 Million	50,000
Journey Medical Corp	969,706.90	$ 56.243 Million	58
Tg Therapeutics Inc	968,385.96	$ 386.386 Million	399
Blueprint Medicines Corporation	965,843.64	$ 562.121 Million	582
Akebia Therapeutics Inc	953,139.18	$ 184.909 Million	194
Alnylam Pharmaceuticals Inc	939,239.60	$ 2,348.099 Million	2,500
Corcept Therapeutics Inc	938,967.12	$ 685.446 Million	730
Biomarin Pharmaceutical Inc	915,935.11	$ 2,950.227 Million	3,221
Regeneron Pharmaceuticals Inc	914,062.30	$ 14,085.700 Million	15,410
Day One Biopharmaceuticals Inc	909,674.16	$ 161.922 Million	178
Masimo Corp	897,136.36	$ 1,973.700 Million	2,200
Elutia Inc	896,961.54	$ 23.321 Million	26
Y mabs Therapeutics inc	886,560.00	$ 88.656 Million	100
Fennec Pharmaceuticals Inc	883,200.00	$ 30.912 Million	35
Esperion Therapeutics Inc	882,904.76	$ 259.574 Million	294
Alector Inc	857,660.19	$ 88.339 Million	103
Merck and Co Inc	852,293.33	$ 63,922.000 Million	75,000
Carlisle Companies Incorporated	847,949.15	$ 5,002.900 Million	5,900
Pacira Biosciences inc	847,734.62	$ 702.772 Million	829

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.